Cognitive-behavioral therapy for medical non-adherence: A topical review and clinical recommendations

Medical non-adherence, particularly among youth with chronic health conditions, represents a critical challenge in the healthcare system of the United States. Around 20% of youth experience chronic illness, yet many fail to adhere to prescribed treatments, leading to serious health consequences, including poor disease management and increased healthcare costs. Factors such as lack of understanding, painful treatment administration, forgetfulness, and mood disorders, particularly anxiety, compound the problem of non-adherence. This review focuses on the effectiveness of Cognitive Behavioral Therapy (CBT) in addressing non-adherence, with particular attention to pill-swallowing difficulties, asthma, type 1 diabetes, and inflammatory bowel disease (IBD).

Contextual Variables

Non-adherence is heavily influenced by sociocultural factors, with marginalized communities experiencing greater challenges. For example, language barriers and distrust of the healthcare system impact treatment adherence. Moreover, the COVID-19 pandemic further exacerbated non-adherence, especially among children with chronic conditions like asthma, IBD, and type 1 diabetes, due to disrupted routines and limited access to healthcare. CBT interventions must, therefore, be contextually responsive, accounting for these sociocultural and pandemic-related disruptions.

Brief Overview of CBT

CBT is a well-established form of psychotherapy, widely regarded as an effective intervention for improving adherence. It integrates principles of learning theory and cognitive science to address behavioral and emotional challenges that affect health outcomes. CBT has shown success in managing internalizing and externalizing disorders, with modular CBT—incorporating psychoeducation, basic behavioral tasks, cognitive restructuring, and behavioral experiments—being particularly useful for addressing medical non-adherence.

CBT for Specific Conditions

1. Pill-Swallowing Difficulties: Many pediatric patients struggle with swallowing pills, which is often due to fear of choking or mood disturbances. CBT has been successful in training children to swallow pills using behavioral techniques like shaping, modeling, and graduated exposure, with success rates as high as 87% in some studies.
2. Asthma Management: Pediatric asthma patients, especially adolescents, face difficulties adhering to inhaler use, which can result in exacerbations and poor disease management. CBT, particularly through eHealth interventions and peer-led programs, has shown promise in improving adherence by addressing emotional, cognitive, and behavioral factors.
3. Type 1 Diabetes Management: Managing type 1 diabetes requires strict adherence to blood glucose monitoring and insulin use, which can be particularly challenging for adolescents. CBT interventions, such as positive reinforcement, goal-setting, and problem-solving techniques, have improved adherence and glycemic control in pediatric patients.
4. Inflammatory Bowel Disease (IBD): Adherence to IBD treatment is complicated by the emotional burden of chronic illness. CBT helps patients manage anxiety, depression, and stress, improving adherence and disease outcomes. Studies show that interventions like problem-solving training significantly enhance adherence in pediatric patients.

Limitations and Future Directions

Despite the success of CBT in addressing medical non-adherence, there are limitations to the research, including small sample sizes and underrepresentation of marginalized communities. Future studies should aim to address these limitations through larger, more diverse sample populations, and by employing more sophisticated research methods such as mediator and moderator analyses.

Conclusions

CBT has proven to be a promising intervention for addressing medical non-adherence in pediatric patients with chronic illnesses. By addressing the emotional, cognitive, and behavioral factors that contribute to non-adherence, CBT offers a viable solution to improving health outcomes. However, further research is needed to refine these interventions and ensure their effectiveness across diverse populations.

Full text

https://www.xiahepublishing.com/2572-5505/JERP-2023-00008

The study was recently published in the Journal of Exploratory Research in Pharmacology.

Journal of Exploratory Research in Pharmacology (JERP) publishes original innovative exploratory research articles, state-of-the-art reviews, editorials, short communications that focus on novel findings and the most recent advances in basic and clinical pharmacology, covering topics from drug research, drug development, clinical trials and application.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.